Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson’s disease. Benabid AL, Chabardes S, Mitrofanis J, Pollak P. Lancet Neurol. 2009 Jan;8(1):67-81. doi: 10.1016/S1474-4422(08)70291-6. Review.
Parkinson’s disease. Kalia LV, Lang AE. Lancet. 2015 Aug 29;386(9996):896-912. doi: 10.1016/S0140-6736(14)61393-3. Epub 2015 Apr 19. Review.
Non-motor features of Parkinson disease. Schapira AHV, Chaudhuri KR, Jenner P. Nat Rev Neurosci. 2017 Jul;18(7):435-450. doi: 10.1038/nrn.2017.62. Epub 2017 Jun 8. Review.
McCarthy & Yeowell (2017) Newspaper response to the back-pain myth busting advice: bruising but helpful. British Journal of Sports Medicine 51: 758.
[1] Cancer Research UK, https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer, Accessed June 2019.
[2] National Institute for Health and Care Excellence (2019) Prostate Cancer (NICE Guideline NG131). Available at: https://www.nice.org.uk/guidance/ng131 [Accessed 12 June 2019].
[1] Bowel Cancer UK. Bowel Cancer Awareness Month 2019 | Bowel Cancer UK [Internet]. [cited 2019 Mar 26]. Available from: https://www.bowelcanceruk.org.uk/support-us/bowel-cancer-awareness-month/
[2] Public Health England. NHS bowel cancer screening (BCSP) programme [Internet]. 2015 [cited 2019 Mar 26]. Available from: https://www.nhs.uk/conditions/bowel-cancer-screening/
[3] Bowel cancer UK. About Bowel Cancer | Bowel Cancer UK [Internet]. 2018 [cited 2019 Mar 26]. Available from: https://www.bowelcanceruk.org.uk/about-bowel-cancer/bowel-cancer/
[4] British Medical Journal. BMJ Best Practices Colorectal Cancer [Internet]. BMJ Publ. Group; 2017 [cited 2019 Mar 26]. Available from: https://bestpractice.bmj.com/topics/en-gb/258
[5] Mayo Clinic. Colon cancer – Diagnosis and treatment – Mayo Clinic [Internet]. Mayo Foundation for Medical Education and Research (MFMER). [cited 2019 Mar 26]. Available from: https://www.mayoclinic.org/diseases-conditions/colon-cancer/diagnosis-treatment/drc-20353674
[6] Cancer Research UK. Bowel cancer survival statistics | Cancer Research UK [Internet]. Cancer Research UK. 2014 [cited 2019 Mar 26]. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bowel-cancer/survival
[1] Public Health England (2016). HIV in the UK: 2016 report [online]. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/602942/HIV_in_the_UK_report.pdf [Accessed 20 Sep. 2018]
[2] Page-Shafer K et al. Risk of HIV infection attributable to oral sex among men who have sex with men and in the population of men who have sex with men. AIDS 2002;16:2350-22.
[3] Coutsoudis A, Kwaan L, Thomson M. Prevention of vertical transmission of HIV-1 in resource-limited settings. Expert review of anti-infective therapy 2010;8:1163-75
[4] Public Health England (2017).Towards elimination of HIV transmission, AIDS and HIV-related deaths in the UK [online]. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/675809/Towards_elimination_of_HIV_transmission_AIDS_and_HIV_related_deaths_in_the_UK.pdf [Accessed 19 Sep. 2018]
[5] National AIDS Trust (2014). HIV and Black African Communities in the UK. June 2014: A Policy Report [online]. Available at: https://www.nat.org.uk/sites/default/files/publications/NAT-African-Communities-Report-June-2014-FINAL.pdf [Accessed 19 Sep. 2018]
[6] Public Health England (2017). Shooting Up: Infections among people who inject drugs in the UK, 2016 [online]. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/663003/Shooting_Up_2017_report.pdf [Accessed 19 Sep. 2018]
[7] NHS Conditions. HIV and AIDS Treatment [online]. Available at: https://www.nhs.uk/conditions/hiv-and-aids/treatment/ [Accessed 19 Sep. 2018.
[8] Albert J et al. Risk of HIV transmission from patients on antiretroviral therapy: A position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy. Scandinavian journal of infectious diseases 2014;46:673-7
[1] Singer, M., Deutschman, C., Seymour, C., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G., Chiche, J., Coopersmith, C., Hotchkiss, R., Levy, M., Marshall, J., Martin, G., Opal, S., Rubenfeld, G., van der Poll, T., Vincent, J. and Angus, D. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), p.801.
[2] American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. (1992). Critical Care Medicine, 20(6), pp.864-874.
[3] McPherson, D., Griffiths, C., Williams, M., Baker, A., Klodawski, E., Jacobson, B. and Donaldson, L. (2018). Sepsis-associated mortality in England: an analysis of multiple causes of death data from 2001 to 2010.
[4] UK Parliament. (2015). Sepsis: Written question – 10526. [online] Available at: https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2015-09-16/10526/ [Accessed 13 Aug. 2018].
[5] NHS England (2017). Second sepsis action plan. [online] Available at: https://www.england.nhs.uk/wp-content/uploads/2017/09/second-sepsis-action-plan.pdf [Accessed 13 Aug. 2018].
[6] NHS England (2015). Improving outcomes for patients with sepsis – A cross-system action plan. [online] Available at: https://www.england.nhs.uk/wp-content/uploads/2015/08/Sepsis-Action-Plan-23.12.15-v1.pdf [Accessed 13 Aug. 2018].
[7] Herrán-Monge, R., Muriel-Bombín, A., García-García, M., Merino-García, P., Martínez-Barrios, M., Andaluz, D., Ballesteros, J., Domínguez-Berrot, A., Moradillo-Gonzalez, S., Macías, S., Álvarez-Martínez, B., Fernández-Calavia, M., Tarancón, C., Villar, J. and Blanco, J. (2017). Epidemiology and Changes in Mortality of Sepsis After the Implementation of Surviving Sepsis Campaign Guidelines. Journal of Intensive Care Medicine, p.088506661771188.
[8] Daniels, R., Nutbeam, T., McNamara, G. and Galvin, C. (2010). The sepsis six and the severe sepsis resuscitation bundle: a prospective observational cohort study. Emergency Medicine Journal, 28(6), pp.507-512.
[9] Dellinger, R., Levy, M., Carlet, J., Bion, J., Parker, M., Jaeschke, R., Reinhart, K., Angus, D., Brun-Buisson, C., Beale, R., Calandra, T., Dhainaut, J., Gerlach, H., Harvey, M., Marini, J., Marshall, J., Ranieri, M., Ramsay, G., Sevransky, J., Thompson, B., Townsend, S., Vender, J., Zimmerman, J. and Vincent, J. (2007). Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Medicine, 34(1), pp.17-60.
[1] Andreyev HJ, Norman AR, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer. 1998;34(4):503-9.
[2] Chute CG, Greenberg ER, Baron J, Korson R, Baker J, Yates J. Presenting conditions of 1539 population-based lung cancer patients by cell type and stage in New Hampshire and Vermont. Cancer. 1985;56(8):2107-11.
[3] Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980;69(4):491-7.
[4] Wigmore SJ, Plester CE, Richardson RA, Fearon KC. Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer. 1997;75(1):106-9.
[5] Bozzetti F, Migliavacca S, Scotti A, Bonalumi MG, Scarpa D, Baticci F, et al. Impact of cancer, type, site, stage and treatment on the nutritional status of patients. Ann Surg. 1982;196(2):170-9.
[6] van Eys J. Effect of nutritional status on responses to therapy. Cancer Res. 1982;42(2 Suppl):747s-53s.
[7] Tubiana M, Attie E, Flamant R, Gerard-Marchant R, Hayat M. Prognostic factors in 454 cases of Hodgkin’s disease. Cancer Res. 1971;31(11):1801-10.
[8] Swenerton KD, Legha SS, Smith T, Hortobagyi GN, Gehan EA, Yap HY, et al. Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res. 1979;39(5):1552-62.
[9] Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G, Muscaritoli M, et al. ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology. Clin Nutr. 2009;28(4):445-54
[10] Von Meyenfeldt MF, Meijerink WJHJ, Rouflart MMJ, Builmaassen MTHJ, Soeters PB. Perioperative Nutritional Support – a Randomized Clinical-Trial. Clin Nutr. 1992;11(4):180-6.
[11] Shirai Y, Okugawa Y, Hishida A et al, Fish oil-enriched nutrition combined with systemic chemotherapy for gastrointestinal cancer patients with cancer cachexia. Sci Rep. 2017;7(1):4826.
[12] Mir O, Coriat R, Blanchet B, et al. Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma. PLOS One. 2012;7(5): e37563.
[13] Miyake M, Morizawa Y, Hori S, et al. Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder. BMC Cancer, 2017;17:237.
[1] NICE (2016). Head Lice: Management.
[2] Hill, N., Moor, G., Cameron, M., Butlin, A., Preston, S., Williamson, M. and Bass, C. (2005). Single blind, randomised, comparative study of the Bug Buster kit and over the counter pediculicide treatments against head lice in the United Kingdom. BMJ, 331(7513), pp.384-387.
[3] Burgess, Lee and Brown (2009). Randomised, controlled, parallel group clinical trials to evaluate the efficacy of isopropyl myristate/cyclomethicone solution. The Pharmaceutical Journal.
[4] Burgess (2016). Head lice: resistance and treatment options. The Pharmaceutical Journal.
[5] Burgess, I., Lee, P. and Matlock, G. (2007). Randomised, Controlled, Assessor Blind Trial Comparing 4% Dimeticone Lotion with 0.5% Malathion Liquid for Head Louse Infestation. PLoS ONE, 2(11), p.e1127.
[1] Schwartz, P., Stramba-Badiale, M., Crotti, L., Pedrazzini, M., Besana, A., Bosi, G., Gabbarini, F., Goulene, K., Insolia, R., Mannarino, S., Mosca, F., Nespoli, L., Rimini, A., Rosati, E., Salice, P. and Spazzolini, C. (2009). Prevalence of the Congenital Long-QT Syndrome. Circulation, 120(18), pp.1761-1767.
[2] Medeiros-Domingo, A., Iturralde-Torres, P. and Ackerman, M. (2007). Clinical and Genetic Characteristics of Long QT Syndrome. Revista Española de Cardiología (English Edition), 60(7), pp.739-752.
[3] Weissler-Snir, A., Gollob, M., Chauhan, V., Care, M. And Spears, D. (2017). Evaluation of Prolonged QT Interval: Structural Heart Disease Mimicking Long QT Syndrome. Pacing and Clinical Electrophysiology, 40(4), pp.417-424.
[4] Kenigsberg, D., Khanal, S., Kowalski, M. and Krishnan, S. (2007). Prolongation of the QTc Interval Is Seen Uniformly During Early Transmural Ischemia. Journal of the American College of Cardiology, 49(12), pp.1299-1305.
[5] Dohadwala, M., Kamili, F., Estes, N. and Homoud, M. (2017). Atrioventricular block and pause-dependent torsade de pointes. HeartRhythm Case Reports, 3(2), pp.115-119.
[6] Subbiah, R., Gollob, M., Gula, L., Davies, R., Leong-Sit, P., Skanes, A., Yee, R., Klein, G. and Krahn, A. (2010). Torsades de pointes during complete atrioventricular block: Genetic factors and electrocardiogram correlates. Canadian Journal of Cardiology, 26(4), pp.208-212.
[7] NHS Greater Glascow and Clyde (2012). DRUG INDUCED QT PROLONGATION. Post Script Extra.
[8] Lee, Y., Choi, J., Bae, E., Park, W., Lee, H. and Oh, P. (2015). The corrected QT (QTc) prolongation in hyperthyroidism and the association of thyroid hormone with the QTc interval. Korean Journal of Pediatrics, 58(7), p.263.
[9] Torsades de pointes cardiac arrest associated with severe hypothyroidism. (2014). British Journal of Cardiology.
[10] Ludomirsky, A., Klein, H., Sarelli, P., Becker, B., Hoffman, S., Taitelman, U., Barzilai, J., Lang, R., David, D., DiSegni, E. and Kaplinsky, E. (1982). Q-T prolongation and polymorphous (“torsade de pointes”) ventricular arrhythmias associated with organophosphorus insecticide poisoning. The American Journal of Cardiology, 49(7), pp.1654-1658.
[11] Little, R., Kay, G., Cavender, J., Epstein, A. And Plumb, V. (1990). Torsade de Pointes and T-U Wave Alternans Associated with Arsenic Poisoning. Pacing and Clinical Electrophysiology, 13(2), pp.164-170
[12] Khan, J., Prasad, N. and Glancy, J. (2009). QTc prolongation during therapeutic hypothermia: are we giving it the attention it deserves?. Europace, 12(2), pp.266-270.
[13] Resuscitation Council (UK) (2015). Adult Basic Life Support and Automated External Defibrillation.
[14] Cho, Y. (2016). Management of Patients with Long QT Syndrome. Korean Circulation Journal, 46(6), p.747.
[15] Schwartz, P. (2004). Left Cardiac Sympathetic Denervation in the Management of High-Risk Patients Affected by the Long-QT Syndrome. Circulation, 109(15), pp.1826-1833.
Irritable bowel syndrome in adults: diagnosis and management. NICE. https://www.nice.org.uk/guidance/cg61
Al Aradi IK, Alawadhi SA, Alkawaja FA. Earlobe keloids: A pilot study of the efficacy of keloidectomy with core fillet flap and adjuvant intralesional corticosteroids. Dermatol Surg 2013;39:1514-9.
Cheng LH. Keloid of the earlobe. Laryngoscope 1972 Apr;82(4):673-81.
Goutos I, Ogawa R. Steroid tape: A promising adjunct to scar management.
Scars, Burns & Healing, Volume 3, 2017; DOI: 10.1177/2059513117690937.
Mustoe TA, Cooter RD, Gold MH, et al. International Advisory Panel on Scar Management. International clinical recommendations on scar management. Plast Reconstr Surg 2002; 297: 433-8.
Ogawa R, Yoshitatsu S, Yoshida K, et al. Is radiation therapy for keloids acceptable? The risk of radiation-induced carcinogenesis. Plast Reconstr Surg 2009; 124: 1196-1201.
Ogawa R, Akaishi S, Kuribayashi S, Miyashita T. Keloids and hypertrophic scars can now be cured completely: Recent progress in our understanding of the pathogenesis of keloids and hypertrophic scars and the most promising current therapeutic strategy. J Nippon Med Sch 2016; 83 (2) 46-53.
Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci 2017 18, 606, doi:10.3390/ijms18030606
This article is for information only and should not be used for the diagnosis or treatment of medical conditions. myHealthSpecialist makes no representations as to the accuracy or completeness of any of the information in this article, or found by following any link from this article. Please consult a doctor or other healthcare professional for medical advice.
Anderson, K.N et al. Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat (2014) 144: 1. doi:10.1007/s10549-014-2852-7
Dumitrescu RG et al. Understanding breast cancer risk – where do we stand in 2005? Journal of Cellular and Molecular Medicine. January 2005. DOI: 10.1111/j.1582-4934.2005.tb0035
Ferlay J et al. Global burden of breast cancer. Breast Cancer Epidemiology: 1-19. 2009
Gierisch JM et al. Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review. Cancer Epidemiology Biomarkers and Prevention. DOI: 10.1158/1055-9965.EPI-13-0298
Hardefeldt PJ et al. Deodorant use and breast cancer risk.. Epidemiology. 2013 Jan;24(1):172
Hardefeldt PJ et al. Diabetes increases the risk of breast cancer: a meta-analysis. Endocr Relat Cancer. 2012 Nov 19;19(6):793-803. doi: 10.1530/ERC-12-0242. Print 2012 Dec.
Kamdar, B.B et al. Night-shift work and risk of breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat (2013) 138: 291. doi:10.1007/s10549-013-2433-1
Key TJ et al. Alcohol, diet, and risk of breast cancer. BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2503
Lu Chen et al. Bra Wearing Not Associated with Breast Cancer Risk: A Population-Based Case–Control Study. Cancer Epidemiology Biomarkers and Prevention. DOI: 10.1158/1055-9965.EPI-14-0414 Published October 2014
King et al. Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2. Science 24 Oct 2003: 302(5645): 643-646
McPherson K et al. Breast cancer – epidemiology, risk factors and genetics. In: ABC of Breast Diseases. Ed. Dixon MJ. BMJ Books
Naro SA. Hormone replacement therapy and the risk of breast cancer. Nature Reviews Clinical Oncology 8, 669-676 (November 011) doi:10.1038/nrclinonc.2011.110
Pinder SE et al. The diagnosis and management of pre-invasive breast disease: Ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) – current definitions and classification. Breast Cancer Research 20035:254
Swerdlow J et al. Breast Cancer Risk After Supradiaphragmatic Radiotherapy for Hodgkin’s Lymphoma in England and Wales: A National Cohort Study. Journal of Clinical Oncology 30(22). 2012
Useful links and acknowledgements
NHS Choice website:
http://www.nhs.uk/conditions/glaucoma/pages/introduction.aspx
International Glaucoma Association. Laser procedures of glaucoma:
https://www.glaucoma-association.com/about-glaucoma/treatments/laser/
https://rohitsharma.doc4care.uk/blog/selective-laser-trabeculoplasty-for-glaucoma-treatment
British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Jordan KM et al. Rheumatology 2007;46(8):1372-4.